ECONOMIC EVALUATION OF BEVACIZUMAB VERSUS RANIBIZUMAB IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN CHINA

被引：0
|
作者：
Li, H. [1 ]
Li, X. [2 ]
Xie, F. [3 ]
机构：
[1] China Pharmaceut Univ, Nanjing, Jiangsu, Peoples R China
[2] Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China
[3] McMaster Univ, Hamilton, ON, Canada
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.385
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSS8
引用
收藏
页码：A782 / A782
页数：1
相关论文
共 50 条
  • [41] Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration.
    Folk, James C.
    Stone, Edwin M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (17): : 1648 - 1655
  • [42] Review of Ranibizumab Trials for Neovascular Age-Related Macular Degeneration
    Patel, Ravi D.
    Momi, Rominder S.
    Hariprasad, Seenu M.
    [J]. SEMINARS IN OPHTHALMOLOGY, 2011, 26 (06) : 372 - 379
  • [43] A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration
    Dae Hyun Park
    Hae Jung Sun
    Sung Jin Lee
    [J]. International Ophthalmology, 2017, 37 : 1205 - 1214
  • [44] The efficacy of aflibercept in the treatment of neovascular age-related macular degeneration previously treated with bevacizumab or ranibizumab
    Hall, Laura
    Zebardast, Nazlee
    Adelman, Ron
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [45] COST UTILITY ANALYSIS OF AFLIBERCEPT, RANIBIZUMAB, AND BEVACIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Lin, C. W.
    Hay, J.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A287 - A287
  • [46] Therapeutic effects of ranibizumab in neovascular age-related macular degeneration
    Ciulla, Thomas A.
    [J]. EXPERT REVIEW OF OPHTHALMOLOGY, 2007, 2 (05) : 679 - 693
  • [47] A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration
    Park, Dae Hyun
    Sun, Hae Jung
    Lee, Sung Jin
    [J]. INTERNATIONAL OPHTHALMOLOGY, 2017, 37 (05) : 1205 - 1214
  • [48] Switching from ranibizumab and aflibercept to bevacizumab therapy in neovascular age-related macular degeneration patients
    Calugaru, Dan
    Calugaru, Mihai
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (05) : NP1 - NP2
  • [49] SHORT-TERM EFFECTIVENESS OF INTRAVITREAL BEVACIZUMAB VERSUS RANIBIZUMAB INJECTIONS FOR PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Chang, Tom S.
    Kokame, Gregg
    Casey, Raynor
    Prenner, Jonathan
    Feiner, Leonard
    Anderson, Nick
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (09): : 1235 - 1241
  • [50] Comparative Study of Ranibizumab versus Bevacizumab in the Treatment of Neovascular Age-Related Macular Degeneration With a 1+PRN Regimen
    Carneiro, A. M.
    Mendonca, L.
    Falcao, M.
    Fonseca, S.
    Brandao, E.
    Falcao-Reis, F.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
12345